Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rod Rezaee

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|January 26, 2019
Post-radiotherapy PET/CT for predicting treatment outcomes in head and neck cancer after postoperative radiotherapyYan Li, Musaddiq J Awan, Tangel Chang, et al.
The Laryngoscope|June 3, 2022
Post-operative Outcomes in Pediatric Patients Following Facial Reconstruction With Fibula Free FlapsAllison A Slijepcevic, Mark K Wax, Matthew Hanasono, et al.
JCO Oncology Practice|May 11, 2021
African Americans With p16+ and p16- Oropharyngeal Squamous Cell Carcinomas Have Distinctly Poor Treatment Outcomes Independent of Medical Care AccessW Quinn O'Neill, Jay Wasman, Jason Thuener, et al.
Laryngoscope Investigative Otolaryngology|August 24, 2022
Treatment failure patterns are similar between p16- and p16+ oropharyngeal squamous cell carcinomasChelsea S Hamill, Richard Grant Muller, Kate Clancy, et al.
Oral Oncology|April 18, 2022
Impact of AJCC 8th edition staging system and definitive treatment choice on the prognosis of complete responders with p16+ and p16- oropharyngeal squamous cell carcinomasR Grant Muller, Chelsea S Hamill, Brandon Vu, et al.
Oral Oncology|April 3, 2021
The tipping point in oral cavity reconstruction: A multi-institutional survey of choice between flap and non-flap reconstructionKenneth E Akakpo, Mark A Varvares, Jeremy D Richmon, et al.
Cancers|October 13, 2021
Impact of p16 Status and Anatomical Site in Anti-PD-1 Immunotherapy-Treated Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma PatientsKate Clancy, Chelsea S Hamill, W Quinn O'Neill, et al.
Cell Reports. Medicine|March 5, 2024
Beta-defensin index: A functional biomarker for oral cancer detectionSantosh K Ghosh, Yuncheng Man, Arwa Fraiwan, et al.
The Laryngoscope|November 8, 2023
Free Flap Outcomes for Head and Neck Surgery in Patients with COVID-19Aaron Domack, Morgan M Sandelski, Syed Ali, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 10, 2022
Thyroid Carcinoma, Version 2.2022, NCCN Clinical Practice Guidelines in OncologyRobert I Haddad, Lindsay Bischoff, Douglas Ball, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
European Journal of Nuclear Medicine and Molecular Imaging|January 26, 2019
Post-radiotherapy PET/CT for predicting treatment outcomes in head and neck cancer after postoperative radiotherapyYan Li, Musaddiq J Awan, Tangel Chang, et al.
The Laryngoscope|June 3, 2022
Post-operative Outcomes in Pediatric Patients Following Facial Reconstruction With Fibula Free FlapsAllison A Slijepcevic, Mark K Wax, Matthew Hanasono, et al.
JCO Oncology Practice|May 11, 2021
African Americans With p16+ and p16- Oropharyngeal Squamous Cell Carcinomas Have Distinctly Poor Treatment Outcomes Independent of Medical Care AccessW Quinn O'Neill, Jay Wasman, Jason Thuener, et al.
Laryngoscope Investigative Otolaryngology|August 24, 2022
Treatment failure patterns are similar between p16- and p16+ oropharyngeal squamous cell carcinomasChelsea S Hamill, Richard Grant Muller, Kate Clancy, et al.
Oral Oncology|April 18, 2022
Impact of AJCC 8th edition staging system and definitive treatment choice on the prognosis of complete responders with p16+ and p16- oropharyngeal squamous cell carcinomasR Grant Muller, Chelsea S Hamill, Brandon Vu, et al.
Oral Oncology|April 3, 2021
The tipping point in oral cavity reconstruction: A multi-institutional survey of choice between flap and non-flap reconstructionKenneth E Akakpo, Mark A Varvares, Jeremy D Richmon, et al.
Cancers|October 13, 2021
Impact of p16 Status and Anatomical Site in Anti-PD-1 Immunotherapy-Treated Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma PatientsKate Clancy, Chelsea S Hamill, W Quinn O'Neill, et al.
Cell Reports. Medicine|March 5, 2024
Beta-defensin index: A functional biomarker for oral cancer detectionSantosh K Ghosh, Yuncheng Man, Arwa Fraiwan, et al.
The Laryngoscope|November 8, 2023
Free Flap Outcomes for Head and Neck Surgery in Patients with COVID-19Aaron Domack, Morgan M Sandelski, Syed Ali, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 10, 2022
Thyroid Carcinoma, Version 2.2022, NCCN Clinical Practice Guidelines in OncologyRobert I Haddad, Lindsay Bischoff, Douglas Ball, et al.
Pageof 5